Science & Enterprise subscription

Follow us on Twitter

  • Many thanks @SciSeeker https://t.co/uQy4yl5pQb
    about 15 hours ago
  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 4 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 4 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 4 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 5 days ago

Please share Science & Enterprise

Infographic – U.S. Venture Funds Near 20-Year Highs

Venture investment chart

Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era. . . . → Read More: Infographic – U.S. Venture Funds Near 20-Year Highs

Immunotherapy Biotech Gains $325M in Venture Funds

Investment graphic

A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds

Stem Cell Start-Up Raises $250M in Venture Funds

T-cell lymphocyte

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

A.I. Chip Start-Up Raises $23M in Early Funds

A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams. . . . → Read More: A.I. Chip Start-Up Raises $23M in Early Funds

Company Launches Attacking Cancer Proteins, Lands $67M

Cancer magnified

A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M

Foundation Supports Muscular Dystrophy RNA Therapy

Nerve cells illustration

A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy. . . . → Read More: Foundation Supports Muscular Dystrophy RNA Therapy

Liquid Biopsy Screening Start-Up Launches, Gains $110M

Blood sample tubes

A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University. . . . → Read More: Liquid Biopsy Screening Start-Up Launches, Gains $110M

Viral Disease Biotech Joins ElevateBio, Gains $120M

T-cells illustration

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M

Start-Up to Use Stem Cells for Hearing Loss

Headphones

A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss

Company Helps Labs Build Gene, Cell Therapy Businesses

DNAmolcule model

A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses